COMMUNIQUÉS West-GlobeNewswire

BEYOND IMMORTALITY: European Wellness Biomedical Group Charts Longevity Through Cell Regeneration Over Organ Transplant
30/09/2025
From hot-mic whispers of World Leaders to groundbreaking science, Prof. Mike Chan reveals why cellular regeneration — not organ swaps, holds the key to extending human healthspan and lifespan. A Whisper in Beijing [...]
Major Wellbeing Organization Selects Aino’s SaaS Platform
30/09/2025
Aino Health AB (publ) has signed an agreement—facilitated through its occupational health collaboration partner Työterveys Aalto Occupational Health Care —with a leading wellbeing sector organization, covering 11,000 [...]
Sequana Medical’s alfapump® System Featured in Presentation at 2025 Portal Intervention Symposium
30/09/2025
Dr. Rahul Patel of Icahn School of Medicine at Mount Sinai presented “alfapump®: Totally Implantable Peritoneal Drain Pump with Urinary Bladder Drainage” Ghent, Belgium – September 30, 2025 – Sequana Medical NV ( [...]
Clinical Match Me Announces Strategic Partnership with NPACE
30/09/2025
Clients to Benefit from Exclusive Discounts and Enhanced Educational Opportunities San Juan, PR, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Clinical Match Me , a transformative force in Nurse Practitioner education, NP [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 39 - 2025
30/09/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 22 Septembre au 26 Septembre 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 39 - 2025
30/09/2025
Aggregated presentation by day and by market Statement of transactions in own shares from September 22nd to September 26th 2025 Name of the issue Identity code of the issuer (Legal Entity Identifier) Day of the [...]
AB Science annonce annonce un léger décalage de la publication de son rapport financier du premier semestre 2025
30/09/2025
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE UN LEGER DECALAGE DE LA PUBLICATION DE SON RAPPORT FINANCIER SEMESTRIEL 2025 LA SOCIETE PUBLIERA SON RAPPORT FINANCIER SEMESTRIEL 2025 LE 10 OCTOBRE 2025 AU PLUS TARD Paris, 30 [...]
AB Science announces a slight delay in the publication of its 2025 half-year financial report
30/09/2025
PRESS RELEASE AB SCIENCE ANNOUNCES A SLIGHT DELAY IN THE PUBLICATION OF ITS 2025 HALF-YEAR FINANCIAL REPORT THE COMPANY WILL PUBLISH ITS HALF-YEAR FINANCIAL REPORT FOR 2025 ON OCTOBER 10, 2025, AT THE LATEST Paris, [...]
Memorial Health Group Highlights 25 Years of Medical Excellence With Advanced Technology and Comprehensive Check-Up Programs
30/09/2025
Photo: Memorial Hospital Bahcelievler, Istanbul ISTANBUL, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Memorial Health Group , one of Turkey’s largest private healthcare providers, is showcasing its combination of 25 years of [...]
Renouvellement complet du Conseil d'administration Élection du Dr Markus Cappel en tant que Président du Conseil d'administration
30/09/2025
Renouvellement complet du Conseil d'administration Élection du Dr Markus Cappel en tant que Président du Conseil d'administration NANTES, France, 30 septembre 2025, 19 heures 30 – OSE Immunotherapeutics SA (ISIN: [...]
Full renewal of the Board of Directors Election of Dr. Markus Cappel as Chairman of the Board of Directors
30/09/2025
Full renewal of the Board of Directors Election of Dr. Markus Cappel as Chairman of the Board of Directors Nantes, September 30, 2025, 7:30 p.m. CET – OSE Immunotherapeutics (ISIN: FR0012127173; Mnemonic: OSE) held its [...]
ROKIT America Accelerates Expansion in the Americas… Poised to Become a Strategic Hub for Reverse-Aging and Regenerative Medicine Platforms
30/09/2025
NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- ROKIT America, a U.S. subsidiary of AI-driven personalized organ regeneration platform specialist ROKIT Healthcare, is set to accelerate its business expansion across the [...]
SCYNEXIS Announces Positive Results from a Phase 1, Single Ascending Dose and Multiple Ascending Dose Study of its Second-Generation Fungerp (SCY-247)
30/09/2025
No safety concerns or dose limiting toxicities observed SCY-247 was able to achieve target exposures at doses lower than our first-generation fungerp Safety, tolerability, and pharmacokinetic profile support the [...]
Medera Strengthens Leadership Team with Three Key Executive Appointments
30/09/2025
Clinical operations, regulatory affairs, technical expertise, and corporate leadership additions support advancing gene therapy pipeline for cardiovascular diseases BOSTON, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Medera Inc [...]
gammaCore® Non-Invasive Vagus Nerve Stimulation (nVNS) as an Adjunctive Treatment Associated with Improvements in Persistent Post-Concussion Symptoms
30/09/2025
ROCKAWAY, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the publication of a peer-reviewed study in Frontiers [...]
Mainz Biomed to Present the Future of Colorectal Cancer Screening at WEO CRC Screening Committee Meeting
30/09/2025
BERKELEY, Calif. and MAINZ, Germany, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of [...]
Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
30/09/2025
SARASOTA, FL, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery [...]
STRATA Skin Sciences Receives Continued Validation for its Personalized Approach with New Published Study Highlighting XTRAC® Excimer Laser Treatment Combined with a Topical Drug in Psoriasis
30/09/2025
HORSHAM, Pa., Sept. 30, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative [...]
FDA Clears OsteoProbe® (K250216): First-Ever Device Indication for Measuring Bone Material Strength
30/09/2025
SANTA BARBARA, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Active Life Scientific, Inc. (ALSI), a leader in innovative medical devices for bone quality, today announced that the U.S. Food and Drug Administration (FDA) [...]

Pages